CAPTRUST Financial Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.1K	Hold	13,140	–	–	﹤0.01%	3069
2026 Q1	$135K	Hold	13,140	–	–	﹤0.01%	2760
2025 Q4	$82.5K	Hold	13,140	–	–	﹤0.01%	2632
2025 Q3	$39.2K	Hold	13,140	–	–	﹤0.01%	2579
2025 Q2	$25K	Hold	13,140	–	–	﹤0.01%	2465
2025 Q1	$19.2K	Hold	13,140	–	–	﹤0.01%	2322
2024 Q4	$24.3K	Hold	13,140	–	–	﹤0.01%	2268
2024 Q3	$31.1K	Hold	13,140	–	–	﹤0.01%	2254
2024 Q2	$36.1K	Hold	13,140	–	–	﹤0.01%	2160
2024 Q1	$54.9K	Sell	13,140 -408	-3%	-$1.48K	﹤0.01%	2083
2023 Q4	$43.9K	Hold	13,548	–	–	﹤0.01%	2596
2023 Q3	$40.6K	Hold	13,548	–	–	﹤0.01%	2495
2023 Q2	$15.4K	Hold	13,548	–	–	﹤0.01%	2467
2023 Q1	$22.6K	Buy	+13,548	New	+$31.5K	﹤0.01%	2247
2022 Q3	–	Sell	-408	Closed	-$2K	–	2185
2022 Q2	$2K	Hold	408	–	–	﹤0.01%	4420
2022 Q1	$2K	Buy	+408	New	+$2.09K	﹤0.01%	4455

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

CAPTRUST Financial Advisors's ARMP Position: Q2 2026 in Review

CAPTRUST Financial Advisors held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 13,140 shares worth $85.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3069.

CAPTRUST Financial Advisors first reported a position in ARMP in Q1 2022 and has held it in 16 quarters since. The position peaked at $135K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

CAPTRUST Financial Advisors held 13,140 shares of Armata Pharmaceuticals worth $85.1K as of Q2 2026.
CAPTRUST Financial Advisors left its Armata Pharmaceuticals share count unchanged in Q2 2026.
Armata Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3069 holding.
CAPTRUST Financial Advisors first reported a position in Armata Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
CAPTRUST Financial Advisors's Armata Pharmaceuticals position peaked at $135K in Q1 2026.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.